Alpha 2.0
Login Register
» Articles » PMID: 31922950

Need for BCG Vaccination to Prevent TB in High-Incidence Countries and Populations

Overview
Journal Emerg Infect Dis
Specialty Infectious Diseases
Date 2020 Jan 11
PMID 31922950
Citations 5
Authors
Shalini Pooransingh
Sateesh Sakhamuri
Affiliations
Soon will be listed here.
Abstract

An estimated one quarter of persons worldwide are infected with Mycobacterium tuberculosis. In 2018, the World Health Organization issued revised guidance on BCG vaccine for high-risk groups. The World Health Organization should consider guiding countries on a case-by-case basis in developing appropriate BCG policies to deliver equitable healthcare and protect public health.

Citing Articles

Impact of COVID-19 on selected essential public health services - lessons learned from a retrospective record review in the Free State, South Africa.

Heunis C, Chikobvu P, Muteba M, Kigozi-Male G, Engelbrecht M, Mushori P BMC Health Serv Res. 2023; 23(1):1244.

PMID: 37951875 PMC: 10640739. DOI: 10.1186/s12913-023-10166-7.

Advancing tuberculosis management: the role of predictive, preventive, and personalized medicine.

Dohal M, Porvaznik I, Solovic I, Mokry J Front Microbiol. 2023; 14:1225438.

PMID: 37860132 PMC: 10582268. DOI: 10.3389/fmicb.2023.1225438.

Tracking changes in national BCG vaccination policies and practices using the BCG World Atlas.

Lancione S, Alvarez J, Alsdurf H, Pai M, Zwerling A BMJ Glob Health. 2022; 7(1).

PMID: 35039309 PMC: 8764994. DOI: 10.1136/bmjgh-2021-007462.

Prevalence of latent tuberculosis and associated factors in patients with chronic kidney disease on hemodialysis.

Ferreira V, Fonseca C, Bollela V, Romao E, Cardeal da Costa J, Sousa A Rev Lat Am Enfermagem. 2021; 29:e3442.

PMID: 34287541 PMC: 8294786. DOI: 10.1590/1518-8345.3839.3442.

Tuberculosis Skin Test Screening in the National Tuberculosis Program of Trinidad and Tobago.

Chattu V, Sakhamuri S, Motilal S, Pounder L, Persad V, Pierre N Healthcare (Basel). 2020; 8(3).

PMID: 32727008 PMC: 7551204. DOI: 10.3390/healthcare8030236.

References
1.
Colditz G, Brewer T, Berkey C, Wilson M, Burdick E, Fineberg H . Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. JAMA. 1994; 271(9):698-702. View
2.
Houben R, Dodd P . The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling. PLoS Med. 2016; 13(10):e1002152. PMC: 5079585. DOI: 10.1371/journal.pmed.1002152. View
3.
. BCG vaccines: WHO position paper – February 2018. Wkly Epidemiol Rec. 2018; 93(8):73-96. View
4.
Roy A, Eisenhut M, Harris R, Rodrigues L, Sridhar S, Habermann S . Effect of BCG vaccination against Mycobacterium tuberculosis infection in children: systematic review and meta-analysis. BMJ. 2014; 349:g4643. PMC: 4122754. DOI: 10.1136/bmj.g4643. View
5.
Van Der Meeren O, Hatherill M, Nduba V, Wilkinson R, Muyoyeta M, van Brakel E . Phase 2b Controlled Trial of M72/AS01 Vaccine to Prevent Tuberculosis. N Engl J Med. 2018; 379(17):1621-1634. PMC: 6151253. DOI: 10.1056/NEJMoa1803484. View